CoChat

Medication-assisted treatment for opioid addiction: Methadone and buprenorphine

Open access
Saxon, Andrew J., Hser, Yih-Ing, Woody, George, Ling, Walter · 2013 · Journal of Food and Drug Analysis
Cited by 69

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Among agents for opioid addiction treatment, methadone is a full μ-opioid receptor agonist, whereas buprenorphine is a partial agonist. Both are long-acting agents. Buprenorphine has a superior safety profile. Methadone is formulated for oral administration and buprenorphine is formulated for sublingual administration. The U.S. Food and Drug Administration is considering for approval a subdermal buprenorphine implant that has a six-month duration of action. Both medications reduce mortality rates and improve other outcomes. Data from a recent randomized, controlled comparison study (N = 1269) of both medications show better treatment retention with methadone, but reduced illicit opioid use early in treatment with buprenorphine. Risk behaviors for human immunodeficiency virus (HIV) were measured by using the Risk Behavior Survey at baseline, at 12 weeks, and at 24 weeks for study completers. In the 30 days prior to entering treatment, 14.4% of the completers (n = 340) who were randomized to treatment with buprenorphine had shared needles and 14.1% of the completers (n = 391) who were randomized to methadone treatment had shared needles. In the 30 days prior to Week 24, the percentage of patients sharing needles decreased to 2.4% for the buprenorphine group and 4.8% for the methadone group (p < 0.0001). In the 30 days prior to entering treatment, 6.8% of the completers randomized to buprenorphine and 8.2% of the completers randomized to methadone had multiple sexual partners; at Week 24, only 5.2% and 5.1%, respectively, reported multiple partners (p < 0.04).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jfda.2013.09.037

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 69

Metadata

Authors
Saxon, A. J., Hser, Y.-I., Woody, G., & Ling, W.
Venue
Journal of Food and Drug Analysis
Published
2013-12
Volume
21
Issue
4
Pages
S69-S72
ISSN
1021-9498 (ISSN-L)
OpenAlex
W2079622133
Cited by
69
References
4
FWCI
2.84
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Medication-assisted treatment for opioid addiction: Methadone and buprenorphine. https://app.cochat.ai/papers/10.1016/j.jfda.2013.09.037
The paper
Saxon, A. J., Hser, Y.-I., Woody, G., & Ling, W. (2013). Medication-assisted treatment for opioid addiction: Methadone and buprenorphine. Journal of Food and Drug Analysis. https://doi.org/10.1016/j.jfda.2013.09.037

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.